
Wednesday, December 28, 2022 10:39:26 AM
Made tee times
Called my friends
But although it’s 50 degrees
The ground is so cold from arctic blast
That all my plans for tomorrow which seemed reasonable based upon
temperature are for naught.
Didn’t try to lie, didn’t plan on not being able to play..but I will be working upon other aspects of life fulfillment until the snow melts..
The best laid plans of mice and men..
And that happened without people making money if I dont play golf tomorrow..
Thank God no one actively to destroy my financial value..other than democrats

Liked By
Spread the love. Be the first to like this post!
Recent ANVS News
- Current Report Filing (8-k) • Edgar (US Regulatory) • 03/31/2023 01:19:41 PM
- Statement of Changes in Beneficial Ownership (4) • Edgar (US Regulatory) • 02/08/2023 10:12:56 PM
- Statement of Changes in Beneficial Ownership (4) • Edgar (US Regulatory) • 01/20/2023 10:44:43 PM
- Statement of Changes in Beneficial Ownership (4) • Edgar (US Regulatory) • 01/20/2023 10:43:38 PM
- Statement of Changes in Beneficial Ownership (4) • Edgar (US Regulatory) • 01/20/2023 10:41:48 PM
- Statement of Changes in Beneficial Ownership (4) • Edgar (US Regulatory) • 01/20/2023 10:41:47 PM
- Statement of Changes in Beneficial Ownership (4) • Edgar (US Regulatory) • 01/20/2023 10:40:33 PM
- Current Report Filing (8-k) • Edgar (US Regulatory) • 01/06/2023 09:06:37 PM
- Annovis Bio Announces New Appointments to Strengthen Its Senior Leadership Team • PR Newswire (US) • 01/06/2023 12:30:00 PM
- Annovis Bio Announces Third Quarter 2022 Results and Provides Corporate Update • PR Newswire (US) • 11/08/2022 10:35:00 PM
- Quarterly Report (10-q) • Edgar (US Regulatory) • 11/08/2022 09:45:41 PM
- Annovis Bio to Present at the 2022 ThinkEquity Investor Conference • PR Newswire (US) • 10/20/2022 11:30:00 AM
- Annovis Bio Announces Publication of Phase 2a Clinical Data in The Journal of Prevention of Alzheimer's Disease • PR Newswire (US) • 10/11/2022 11:30:00 AM
- H.C. Wainwright Sticks to Its Buy Rating for Annovis Bio (ANVS) • TipRanks • 10/11/2022 08:46:40 AM
- Annovis Bio Shares Rise 6% After FDA Approves Buntanetap Study • Dow Jones News • 10/06/2022 02:34:00 PM
- Annovis Bio Announces FDA Authorization to Proceed with Phase 2/3 Trial for Buntanetap in Alzheimer's Disease • PR Newswire (US) • 10/06/2022 11:30:00 AM
- Annovis Bio to Present at the 2022 Ladenburg Thalmann Healthcare Conference • PR Newswire (US) • 09/29/2022 11:30:00 AM
- Annovis Bio Announces Publication of Patents Covering the Treatment of Amyloid Lateral Sclerosis, Huntington's Disease and Prion Diseases • PR Newswire (US) • 09/13/2022 11:30:00 AM
- Current Report Filing (8-k) • Edgar (US Regulatory) • 09/12/2022 09:10:14 PM
- Annovis Bio's CEO Maria Maccecchini Issues Letter to Stockholders • PR Newswire (US) • 09/08/2022 11:30:00 AM
- Current Report Filing (8-k) • Edgar (US Regulatory) • 08/30/2022 10:05:03 AM
- Annovis Bio Appoints Henry Hagopian III as Chief Financial Officer • PR Newswire (US) • 08/29/2022 08:00:00 PM
- Annovis Bio (ANVS) Gets a Buy from Maxim Group • TipRanks • 08/25/2022 01:45:21 PM
- Annovis Bio Announces First Patient Dosed in Phase 3 Trial in Patients with Early Parkinson's Disease • PR Newswire (US) • 08/24/2022 11:30:00 AM
- Current Report Filing (8-k) • Edgar (US Regulatory) • 08/08/2022 12:31:32 PM
FEATURED Tiziana Life Sciences Announces Anti-CD3 mAb Research for the Treatment of Alzheimer's Disease to be Presented by Dr. Howard Weiner at the International Conference on Alzheimer's and Parkinson's Disease and Related Neurological Disorders Conference • Mar 31, 2023 7:07 AM
ILUS Confirms Further Funding Arrangements and Note Settlement • ILUS • Mar 31, 2023 10:21 AM
Sigyn Therapeutics Announces Filing of 2022 Annual Report on SEC Form 10-K • SIGY • Mar 31, 2023 10:06 AM
ARway Secures Multiple New SDK Deals to Drive Growth in $44B Indoor Positioning and Navigation Market • ARWYF • Mar 30, 2023 10:30 AM
Nextech3D.ai Enters Asian Market with Major 3D Modeling Deal to Revolutionize E-Commerce • NTAR • Mar 30, 2023 10:00 AM
OMID Posts 2022 Annual Report and Provides Update • OMID • Mar 30, 2023 9:15 AM